These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 36157311)

  • 21. Effect of Cold Atmospheric Plasma Therapy vs Standard Therapy Placebo on Wound Healing in Patients With Diabetic Foot Ulcers: A Randomized Clinical Trial.
    Stratmann B; Costea TC; Nolte C; Hiller J; Schmidt J; Reindel J; Masur K; Motz W; Timm J; Kerner W; Tschoepe D
    JAMA Netw Open; 2020 Jul; 3(7):e2010411. PubMed ID: 32672829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A biodegradable polyurethane dermal matrix in reconstruction of free flap donor sites: a pilot study.
    Wagstaff MJ; Schmitt BJ; Coghlan P; Finkemeyer JP; Caplash Y; Greenwood JE
    Eplasty; 2015; 15():e13. PubMed ID: 25987938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Head and Neck Wound Reconstruction Using Biodegradable Temporizing Matrix Versus Collagen-Chondroitin Silicone Bilayer.
    Wu SS; Wells M; Ascha M; Duggal R; Gatherwright J; Chepla K
    Eplasty; 2022; 22():e31. PubMed ID: 36000010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of a novel synthetic nanofibre matrix to treat hard-to-heal wounds.
    Herron K
    J Wound Care; 2022 Nov; 31(11):962-968. PubMed ID: 36367807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human acellular dermal wound matrix for complex diabetic wounds.
    Rupert P
    J Wound Care; 2016 Apr; 25(4):S17-8, S20-1. PubMed ID: 27068343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of a human acellular dermal wound matrix in patients with complex wounds and comorbidities.
    Williams ML; Holewinski JE
    J Wound Care; 2015 Jun; 24(6):261-2, 264-7. PubMed ID: 26075374
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of vacuum-assisted closure (VAC) therapy in the healing of chronic diabetic foot ulcers.
    Nather A; Chionh SB; Han AY; Chan PP; Nambiar A
    Ann Acad Med Singap; 2010 May; 39(5):353-8. PubMed ID: 20535423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A prospective, multicentre, open-label, single-arm clinical trial for treatment of chronic complex diabetic foot wounds with exposed tendon and/or bone: positive clinical outcomes of viable cryopreserved human placental membrane.
    Frykberg RG; Gibbons GW; Walters JL; Wukich DK; Milstein FC
    Int Wound J; 2017 Jun; 14(3):569-577. PubMed ID: 27489115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Community-based care for chronic wound management: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(18):1-24. PubMed ID: 23074522
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Performance of biodegradable temporizing matrix vs collagen-chondroitin silicone bilayer dermal regeneration substitutes in soft tissue wound healing: a retrospective analysis.
    Wu SS; Wells M; Ascha M; Gatherwright J; Chepla K
    Wounds; 2022 Apr; 34(4):106-115. PubMed ID: 35452408
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel use for the biodegradable temporizing matrix.
    Frost SR; Deodhar A; Offer GJ
    Eur J Plast Surg; 2022; 45(6):1015-1020. PubMed ID: 35637749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of diabetic foot wounds with acellular fish skin graft rich in omega-3: a prospective evaluation.
    Woodrow T; Chant T; Chant H
    J Wound Care; 2019 Feb; 28(2):76-80. PubMed ID: 30767649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Synthetic Biodegradable Temporising Matrix in Degloving Lower Extremity Trauma Reconstruction: A Case Report.
    Damkat-Thomas L; Greenwood JE; Wagstaff MJD
    Plast Reconstr Surg Glob Open; 2019 Apr; 7(4):e2110. PubMed ID: 31321161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CO
    Monami M; Mirabella C; Scatena A; Nreu B; Zannoni S; Aleffi S; Giannoni L; Mannucci E
    J Endocrinol Invest; 2017 Aug; 40(8):819-822. PubMed ID: 28260184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomised clinical trial to compare total contact casts, healing sandals and a shear-reducing removable boot to heal diabetic foot ulcers.
    Lavery LA; Higgins KR; La Fontaine J; Zamorano RG; Constantinides GP; Kim PJ
    Int Wound J; 2015 Dec; 12(6):710-5. PubMed ID: 24618113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A pilot study evaluating non-contact low-frequency ultrasound and underlying molecular mechanism on diabetic foot ulcers.
    Yao M; Hasturk H; Kantarci A; Gu G; Garcia-Lavin S; Fabbi M; Park N; Hayashi H; Attala K; French MA; Driver VR
    Int Wound J; 2014 Dec; 11(6):586-93. PubMed ID: 23163982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of tissue engineering products for the management of neuropathic diabetic foot ulcers: an interim analysis.
    Frykberg RG; Cazzell SM; Arroyo-Rivera J; Tallis A; Reyzelman AM; Saba F; Warren L; Stouch BC; Gilbert TW
    J Wound Care; 2016 Jul; 25(Sup7):S18-S25. PubMed ID: 29027848
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bilayered bioengineered skin substitute (Apligraf): a review of its use in the treatment of venous leg ulcers and diabetic foot ulcers.
    Curran MP; Plosker GL
    BioDrugs; 2002; 16(6):439-55. PubMed ID: 12463767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improving wound-healing outcomes in diabetic foot ulcers.
    McLennan SV; McGill M; Twigg SM; Yue DK
    Expert Rev Endocrinol Metab; 2007 Mar; 2(2):205-213. PubMed ID: 30754184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heberprot-P: a novel product for treating advanced diabetic foot ulcer.
    Berlanga J; Fernández JI; López E; López PA; del Río A; Valenzuela C; Baldomero J; Muzio V; Raíces M; Silva R; Acevedo BE; Herrera L
    MEDICC Rev; 2013 Jan; 15(1):11-5. PubMed ID: 23396236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.